**CVS Health Corp Reports Fiscal Year 2025 Results**

CVS Health Corporation (NYSE: CVS) has released its financial results for the fiscal year ended December 31, 2025, reporting total revenues of $402.1 billion, an increase of 7.8% compared to $372.8 billion in 2024. The revenue growth was attributed to gains across all operating segments, with product revenues reaching $249.9 billion, premium revenues at $134.8 billion, and service revenues totaling $15.2 billion. Net investment income also saw an increase, reaching $2.2 billion.

The company's operating costs totaled $397.4 billion, a 9.1% increase from $364.3 billion in the previous year. This rise was primarily due to a $5.7 billion goodwill impairment charge related to the Health Care Delivery reporting unit, $1.2 billion in legacy litigation charges, a $320 million opioid litigation charge, and $288 million in pre-tax losses on Accountable Care assets. Operating income decreased by 45.3% to $4.7 billion, compared to $8.5 billion in 2024. Interest expense increased to $3.1 billion, while a gain on deconsolidation of subsidiary of $483 million was recorded.

CVS Health's net income attributable to CVS Health was $1.8 billion, or $1.39 per diluted share, compared to $4.6 billion, or $3.66 per diluted share, in the prior year. The company's effective income tax rate decreased to 19.1% from 25.4% in the previous year, due to a worthless stock deduction associated with a subsidiary that filed for bankruptcy in 2025, partially offset by the impact of the goodwill impairment charge and the legacy litigation charges recorded during 2025. As of December 31, 2025, the company employed over 300,000 colleagues.

Looking ahead, CVS Health anticipates continued elevated utilization levels in 2026, which may pressure the Health Care Benefits segment and its health care delivery assets. The company also expects continued pressure from clients for lower prices and increased revenue sharing, as well as potential adverse effects from changes in the economic environment and regulatory landscape. The company expects to maintain its quarterly dividend of $0.665 per share throughout 2026.

About CVS HEALTH Corp

CVS Health Corporation is a leading health solutions company offering retail pharmacies, pharmacy benefit management, and health services. Its core segments include health care benefits, pharmacy and consumer wellness, and health services, serving millions through insurance products, primary care clinics, and pharmacy networks. The company focuses on personalized, technology-driven care, cost management, and expanding access to quality healthcare across the U.S. and beyond.

This description was generated via AI from an annual report. Updated 8 months ago.

About 10-K Filings

A 10-K form is a comprehensive annual report that public companies in the United States must file with the SEC, providing a detailed overview of the company's financial condition, performance, and business strategies.

Key points about the 10-K:

  • Frequency: Filed annually, typically within 60 to 90 days after the end of the company's fiscal year.
  • Content: It includes:
    • Detailed financial statements audited by an independent accounting firm
    • Management's Discussion and Analysis (MD&A) of financial condition and results
    • Description of the company's business, properties, and legal proceedings
    • Risk factors and market risks
    • Executive compensation and corporate governance information
  • Importance: Considered the most comprehensive and important document a public company files with the SEC.
  • Length: Often exceeds 100 pages due to its extensive and detailed nature.

Our Methodology

AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.

Our method:

  1. Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
  2. AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
  3. Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
  4. Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
  5. Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Read more about AssetRoom

Feedback & Corrections

Spot an error or have a suggestion? Contact us.